Investor'S Fiduciary Advisor Network, LLC Clearside Biomedical, Inc. Put Options Transaction History
Investor'S Fiduciary Advisor Network, LLC
- $261 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CLSD
# of Institutions
50Shares Held
11.6MCall Options Held
24KPut Options Held
12.1K-
Vanguard Group Inc Valley Forge, PA2.81MShares$2.95 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$2.31 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.93MShares$2.03 Million0.03% of portfolio
-
Black Rock Inc. New York, NY798KShares$838,0430.0% of portfolio
-
Geode Capital Management, LLC Boston, MA764KShares$802,2600.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $63.2M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...